Mepivacaina Con Adrenalina Ogna (Epinephrine Bitartrate, Mepivacaine Hydrochloride)

Mepivacaine blocks voltage‑gated sodium channels on nerve membranes, stopping the transmission of pain signals. Epinephrine stimulates alpha‑adrenergic receptors, causing local blood vessel constriction. This vasoconstriction limits the systemic absorption of mepivacaine, extending its anesthetic effect and reducing bleeding at the treatment site.

The specific dose is determined by the treating dentist or oral surgeon based on the procedure, patient weight, and clinical judgment. Prescribers follow established dental anesthesia guidelines and adjust the volume to stay within recommended maximum limits for safe use.

Safety data for use in pregnancy and lactation are limited. The product should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and it is generally avoided unless specifically indicated by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Both formulations combine an amide local anesthetic with epinephrine for prolonged effect. Mepivacaine has a slightly faster onset and a longer duration than lidocaine, making it advantageous for lengthy dental procedures. Choice between them depends on clinician preference, patient response, and specific procedural requirements.

Mepivacaina Con Adrenalina Ogna should be stored at ambient temperature, protected from light and moisture, and kept in its original sealed container. Avoid freezing the solution, and discard any product that appears discolored or contains particles before use.

The product is supplied as a sterile solution for injection. It is administered by a dental professional via infiltration or nerve block techniques, injecting the solution directly into the tissue surrounding the target tooth or area to achieve localized anesthesia.

Serious risks include severe allergic reactions (anaphylaxis), cardiac arrhythmias, marked hypertension, seizures, and rare cases of methemoglobinemia. Immediate medical attention is required if any of these symptoms occur during or after administration.

Patients with known hypersensitivity to mepivacaine, other amide anesthetics, or epinephrine should avoid this product. It is also contraindicated in individuals with uncontrolled hypertension, certain cardiac arrhythmias, or those taking non‑selective beta‑blockers or MAO inhibitors without close medical supervision.